Wearable Sensors and ePROs for Cancer

This trial explores how wearable sensors and smartphone apps can improve cancer treatment experiences. Participants will use a smartwatch and a mobile app to track their activity and report on their health over four weeks. The researchers aim to determine if this technology, specifically wearable actigraphy (a method of monitoring rest/activity cycles), can assist in early-phase cancer trials. Individuals already participating in a trial at the Cleveland Clinic, who own a smartphone, and can use a smartwatch might be suitable candidates. Participants must feel comfortable using a mobile app and be willing to wear the smartwatch most of the day. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance cancer treatment experiences for future patients.

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using wearable sensors and a mobile app, so it's likely you can continue your current treatment, but please confirm with the trial coordinators.

Past studies have used wearable devices like smartwatches with cancer patients to track activity levels and predict health outcomes. These devices collect movement data and provide insights into a patient's daily activities. Research has shown that these wearable trackers are generally easy to use and safe, with no major safety concerns reported. They are non-invasive, meaning they don't enter the body, which reduces the risk of side effects.

Researchers are excited about using wearable actigraphy and electronic patient-reported outcomes (ePROs) because they offer a fresh approach to monitoring cancer patients. Unlike traditional methods that rely heavily on periodic clinic visits and subjective reports, this technology provides continuous, objective data on a patient's activity levels and experiences. The OncoJourney app allows patients to easily report their symptoms and side effects in real-time, potentially leading to more personalized and timely medical interventions. This innovative approach not only enhances patient engagement but also could lead to improved quality of life and treatment outcomes by enabling more precise adjustments to care plans.

Research has shown that wearable devices, like wristbands, can improve health for cancer patients. In this trial, participants will use wearable actigraphy devices and complete electronic patient-reported outcomes (ePROs) questionnaires on a mobile application called OncoJourney for four weeks. These devices track movement and activity, which is useful because cancer treatments often disrupt sleep and physical activity. Studies have found that these wearables can also predict important health outcomes, such as a patient's response to treatment or their chances of survival. Specifically, for patients undergoing chemotherapy, these trackers have significantly improved physical health. Overall, these devices provide valuable information for monitoring and enhancing cancer care.¹⁵⁶⁷⁸